473 related articles for article (PubMed ID: 26923001)
1. Immune Contexture, Immunoscore, and Malignant Cell Molecular Subgroups for Prognostic and Theranostic Classifications of Cancers.
Becht E; Giraldo NA; Germain C; de Reyniès A; Laurent-Puig P; Zucman-Rossi J; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Adv Immunol; 2016; 130():95-190. PubMed ID: 26923001
[TBL] [Abstract][Full Text] [Related]
2. Cancer immune contexture and immunotherapy.
Becht E; Giraldo NA; Dieu-Nosjean MC; Sautès-Fridman C; Fridman WH
Curr Opin Immunol; 2016 Apr; 39():7-13. PubMed ID: 26708937
[TBL] [Abstract][Full Text] [Related]
3. The continuum of cancer immunosurveillance: prognostic, predictive, and mechanistic signatures.
Galon J; Angell HK; Bedognetti D; Marincola FM
Immunity; 2013 Jul; 39(1):11-26. PubMed ID: 23890060
[TBL] [Abstract][Full Text] [Related]
4. The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non-Small Cell Lung Cancer.
Bremnes RM; Busund LT; Kilvær TL; Andersen S; Richardsen E; Paulsen EE; Hald S; Khanehkenari MR; Cooper WA; Kao SC; Dønnem T
J Thorac Oncol; 2016 Jun; 11(6):789-800. PubMed ID: 26845192
[TBL] [Abstract][Full Text] [Related]
5. The Immunoscore in the Clinical Practice of Patients with Colon and Rectal Cancers.
Zeitoun G; Sissy CE; Kirilovsky A; Anitei G; Todosi AM; Marliot F; Haicheur N; Lagorce C; Berger A; Zinzindohoué F; Galon J; Scripcariu V; Pagès F
Chirurgia (Bucur); 2019; 114(2):152-161. PubMed ID: 31060646
[TBL] [Abstract][Full Text] [Related]
6. Tumor-associated macrophages, nanomedicine and imaging: the axis of success in the future of cancer immunotherapy.
Zanganeh S; Spitler R; Hutter G; Ho JQ; Pauliah M; Mahmoudi M
Immunotherapy; 2017 Sep; 9(10):819-835. PubMed ID: 28877626
[TBL] [Abstract][Full Text] [Related]
7. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications.
Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F
Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857
[TBL] [Abstract][Full Text] [Related]
8. The clinical role of the TME in solid cancer.
Giraldo NA; Sanchez-Salas R; Peske JD; Vano Y; Becht E; Petitprez F; Validire P; Ingels A; Cathelineau X; Fridman WH; Sautès-Fridman C
Br J Cancer; 2019 Jan; 120(1):45-53. PubMed ID: 30413828
[TBL] [Abstract][Full Text] [Related]
9. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
Mola S; Pandolfo C; Sica A; Porta C
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
[TBL] [Abstract][Full Text] [Related]
10. Rational bases for the use of the Immunoscore in routine clinical settings as a prognostic and predictive biomarker in cancer patients.
Kirilovsky A; Marliot F; El Sissy C; Haicheur N; Galon J; Pagès F
Int Immunol; 2016 Aug; 28(8):373-82. PubMed ID: 27121213
[TBL] [Abstract][Full Text] [Related]
11. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
12. Integrating tumor microenvironment with cancer molecular classifications.
Becht E; de Reyniès A; Fridman WH
Genome Med; 2015 Nov; 7(1):115. PubMed ID: 26568192
[TBL] [Abstract][Full Text] [Related]
13. Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
Wu T; Wu X; Wang HY; Chen L
Cancer Commun (Lond); 2019 Apr; 39(1):21. PubMed ID: 30999966
[TBL] [Abstract][Full Text] [Related]
14. Immune infiltration in human cancer: prognostic significance and disease control.
Fridman WH; Galon J; Dieu-Nosjean MC; Cremer I; Fisson S; Damotte D; Pagès F; Tartour E; Sautès-Fridman C
Curr Top Microbiol Immunol; 2011; 344():1-24. PubMed ID: 20512556
[TBL] [Abstract][Full Text] [Related]
15. The Role of Neoantigens in Naturally Occurring and Therapeutically Induced Immune Responses to Cancer.
Ward JP; Gubin MM; Schreiber RD
Adv Immunol; 2016; 130():25-74. PubMed ID: 26922999
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment.
Weinstein AM; Storkus WJ
Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634
[TBL] [Abstract][Full Text] [Related]
17. The immune microenvironment: a major player in human cancers.
Fridman WH; Remark R; Goc J; Giraldo NA; Becht E; Hammond SA; Damotte D; Dieu-Nosjean MC; Sautès-Fridman C
Int Arch Allergy Immunol; 2014; 164(1):13-26. PubMed ID: 24852691
[TBL] [Abstract][Full Text] [Related]
18. Influence of Innate Immunity on Cancer Cell Stemness.
Pastò A; Consonni FM; Sica A
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397392
[TBL] [Abstract][Full Text] [Related]
19. Antibody Blockade of Semaphorin 4D Promotes Immune Infiltration into Tumor and Enhances Response to Other Immunomodulatory Therapies.
Evans EE; Jonason AS; Bussler H; Torno S; Veeraraghavan J; Reilly C; Doherty MA; Seils J; Winter LA; Mallow C; Kirk R; Howell A; Giralico S; Scrivens M; Klimatcheva K; Fisher TL; Bowers WJ; Paris M; Smith ES; Zauderer M
Cancer Immunol Res; 2015 Jun; 3(6):689-701. PubMed ID: 25614511
[TBL] [Abstract][Full Text] [Related]
20. Regulation of CTL Infiltration Within the Tumor Microenvironment.
Church SE; Galon J
Adv Exp Med Biol; 2017; 1036():33-49. PubMed ID: 29275463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
